| Company Name: | Zimmer Holdings, Incorporated | | Ticker Symbol: | ZMH | | | WWW Address: | www.zimmer.com | | CEO: | David C. Dvorak | | No. of Employees: | 8,500 | | Common Issue Type: | CS | | Business Description: | The Company designs, developments, manufactures and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 58.34 |  0.38 | 58.1 | 59.13 | 58.11 | 58.47 | 57.46 | 1515385 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 12,426.4 | 213.0 | 1.07 | 3.72 | 0.00 | 17.5 | 0.0 | 58.47 - 30.67 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 58.34 | $ | | PE Ratio - LTM | 17.5 | |
| Market Capitalisation | 12,425.2 | mil |
| Latest Shares Outstanding | 213.0 | mil |
| Earnings pS (EPS) | 3.72 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 484,835 | $ |
| Effective Tax Rate | 24.3 | % |
| Float | 214.1 | mil |
| Float as % of Shares Outstanding | 99.9 | % |
| Foreign Sales | 1,767 | mil |
| Domestic Sales | 2,354 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 44.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 5.00 | % |
| Gross Profit Margin | 84.3 | % |
| EBITDA Margin | 35.1 | % |
| Pre-Tax Profit Margin | 25.0 | % |
| Assets Turnover | 0.5 | % |
| Return on Assets (ROA) | 9.5 | % |
| Return on Equity (ROE) | 12.2 | % |
| Return on Capital Invested (ROCI) | 11.1 | % |
| Current Ratio | 3.6 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 85.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.10 | |
| LT Debt/Total Capital | 9.0 | % |
| Working Capital pS | 8.32 | $ |
| Cash pS | 2.06 | $ |
| Book-Value pS | 28.07 | $ |
| Tangible Book-Value pS | 10.43 | $ |
| Cash Flow pS | 4.97 | $ |
| Free Cash Flow pS | 0.75 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.08 | |
| Price/Tangible Book Ratio | 5.59 | |
| Price/Cash Flow | 11.7 | |
| Price/Free Cash Flow | 77.4 | |
| P/E as % of Industry Group | 60.0 | % |
| P/E as % of Sector Segment | 8.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.5 | 101 | 18,415 | 29,401 |
| 4 Weeks | 58.47 | 52.17 | 52.57 | 11.0 | 104 | 16,162 | 274,761 |
| 13 Weeks | 58.47 | 46.01 | 47.96 | 21.6 | 113 | 23,233 | 1,417,199 |
| 26 Weeks | 58.47 | 38.55 | 44.55 | 31.0 | 109 | 22,259 | 2,782,423 |
| 52 Weeks | 58.47 | 30.67 | 37.32 | 56.3 | 127 | 23,069 | 5,744,078 |
| YTD | 58.47 | 30.67 | - | 44.3 | 118 | 23,683 | 5,376,108 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 57.62 | 56.67 | 53.73 | 47.68 | 45.08 | 1.07 | 1.10 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 6.94 | 93.1 | 5.23 |
| Income | 10.95 | 67.1 | 1.59 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 5.41 | NA | 83.82 |
| R&D | 6.07 | NA | 2.12 |
| Normalized Inc. | 9.42 | NA | 2.70 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -3.3 | 2.5 | 5.7 |
| Earnings % | -17.5 | -30.2 | 9.8 |
| EPS % | -12.8 | -26.3 | 14.1 |
| EPS $ | -0.38 | -0.25 | 0.46 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 19.44 |
| Current Ratio | 2.8 |
| Quick Ratio (Acid Test) | 1.2 |
| Liquidity Ratio (Cash) | 0.28 |
| Receivables Turnover | 5.9 |
| Average Collection Period | 61 |
| Working Capital/Equity | 24.9 |
| Working Capital pS | 6.32 |
| Cash-Flow pS | 5.04 |
| Free Cash-Flow pS | 0.35 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 6.20 |
| Financial Leverage Ratio (Assets/Equity) | 1.3 |
| Debt Ratio | 21.9 |
| Total Debt/Equity (Gearing Ratio) | 0.08 |
| LT Debt/Equity | 0.08 |
| LT Debt/Capital Invested | 13.4 |
| LT Debt/Total Liabilities | 29.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 8.40 |
| Tobin's Q Ratio | 1.72 |
| Current P/E Ratio - LTM | 17.50 |
| Enterprise Value (EV)/EBITDA | 9.63 |
| Enterprise Value (EV)/Free Cash Flow | 209.91 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 5.59 |
| Price/Book Ratio - LTM | 2.08 |
| Price/Cash Flow Ratio | 11.7 |
| Price/Free Cash Flow Ratio - LTM | 77.4 |
| Price/Sales Ratio | 3.09 |
| P/E Ratio (1 month ago) - LTM | 16.4 |
| P/E Ratio (26 weeks ago) - LTM | 12.4 |
| P/E Ratio (52 weeks ago) - LTM | 9.1 |
| 5-Y High P/E Ratio | 40.8 |
| 5-Y Low P/E Ratio | 9.2 |
| 5-Y Average P/E Ratio | 22.8 |
| Current P/E Ratio as % of 5-Y Average P/E | 77 |
| P/E as % of Industry Group | 60.0 |
| P/E as % of Sector Segment | 8.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 16.1 |
| PER SHARE FIGURES |
| LT Debt pS | 2.06 |
| Current Liabilities pS | 3.46 |
| Tangible Book Value pS - LTM | 10.43 |
| Book Value pS - LTM | 28.07 |
| Capital Invested pS | 28.69 |
| Cash pS - LTM | 2.06 |
| Cash Flow pS - LTM | 4.97 |
| Free Cash Flow pS - LTM | 0.75 |
| Earnings pS (EPS) | 3.72 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 1.89 |
| Free Cash Flow Margin 5YEAR AVG | 16.07 |
| Net Profit Margin | 20.6 |
| Net Profit Margin - 5YEAR AVRG. | 21.0 |
| Equity Productivity | 0.73 |
| Return on Equity (ROE) | 15.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 15.1 |
| Capital Invested Productivity | 0.67 |
| Return on Capital Invested (ROCI) | 13.9 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 14.3 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | 11.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 11.9 |
| Gross Profit Margin | 84.3 |
| Gross Profit Margin - 5YEAR AVRG. | 82.5 |
| EBITDA Margin - LTM | 35.1 |
| EBIT Margin - LTM | 25.3 |
| Pre-Tax Profit Margin | 27.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 29.2 |
| Effective Tax Rate | 24.3 |
| Effective Tax Rate - 5YEAR AVRG. | 28.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 477 |
| Revenue per Employee | 484,835 |
| Net Income per Employee | 99,835 |
| Average Collection Period | 64 |
| Receivables Turnover | 5.9 |
| Day's Inventory Turnover Ratio | 413 |
| Inventory Turnover | 0.9 |
| Inventory/Sales | 22.5 |
| Accounts Payble/Sales | 4.52 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 2.93 |
| Fixed Assets Turnover | 0.81 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 19.38 |
| Revenue per $ Plant | 3.26 |
| Revenue per $ Common Equity | 0.73 |
| Revenue per $ Capital Invested | 0.67 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 43.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 39.7 |
| Research & Devlopment (R&D) as % of Revenue | 4.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 4.7 |
|
|  
| | |  |  | |
| |